EMAMI Latest Share Price (EMAMILTD)
TODAY IN ONE LINE
EMAMILTD slipped 0.5% on light volume, lagging Nifty's 1.1% move.
With a market cap of ₹16,163.59 Cr., it trades at a P/E of 21.60. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
EMAMI flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Capital EfficiencyROCE of 26.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 26.7%
- ●Healthy Operating MarginsOPM is structurally strong at 29.6%
- ●High Promoter HoldingPromoters hold 54.5% skin-in-the-game
- ●Steady Dividend YieldReliable 2.73% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.02x
- ●FII AccumulationFII holding increased by 1.15% QoQ
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 11.8% YoY
Latest EMAMI News
What changed recently?
Recent events, corporate actions, and announcements.
EMAMI valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for EMAMI, framed against the sector median so the premium or discount is obvious at a glance.
EMAMI trades at a P/E of 21.60× and P/B of 5.53×, against the Fast Moving Consumer Goods sector median P/E of 29.79×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
EMAMI technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for EMAMI — derived from the latest tape, not yesterday's close.
EMAMI last traded at ₹370.9 with an intraday range of ₹368.35–₹374 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹370.90| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 385.12 | +14.22 | +3.83% |
| R3 | 379.47 | +8.57 | +2.31% |
| R2 | 376.73 | +5.83 | +1.57% |
| R1 | 373.82 | +2.92 | +0.79% |
| PIVOT | 371.08 | 0.18 | 0.05% |
| CURRENT | 370.90 | — | — |
| S1 | 368.17 | -2.73 | -0.74% |
| S2 | 365.43 | -5.47 | -1.47% |
| S3 | 362.52 | -8.38 | -2.26% |
| S4 | 356.87 | -14.03 | -3.78% |
EMAMILTD is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹368.35–₹373.2
Trading Inside opening range
EMAMI financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for EMAMI — consolidated or standalone — with margins, YoY growth and key ratios inline.
EMAMI reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹16,163.59 Cr. and reported EPS of ₹17.27.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 3,780 | 3,780 ▲ 0.0% |
| Sales Growth YoY %Derived | -0.78% | -0.78% |
| Other Income | 85 | 85 ▲ 0.0% |
| Total Income | 3,865 | 3,865 ▲ 0.0% |
| 1,138 | 1,138 ▲ 0.0% | |
| Gross ProfitDerived | 2,642 | 2,642 ▲ 0.0% |
| Gross Margin %Derived | 69.89% | 69.89% |
| 1,678 | 1,678 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 964 | 964 ▲ 0.0% |
| OPM %Derived | 25.50% | 25.50% |
| 178 | 178 ▲ 0.0% | |
| Profit Before Tax (PBT) | 850 | 850 ▲ 0.0% |
| 71 | 71 ▲ 0.0% | |
| Effective Tax %Derived | 8.33% | 8.33% |
| Total Profit for Period | 775 | 775 ▲ 0.0% |
| Less: Non-controlling Interests | -0 | -0 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 775 | 775 ▲ 0.0% |
| Net Profit Margin %Derived | 20.51% | 20.51% |
| PAT Growth YoY %Derived | -3.87% | -3.87% |
| Earnings Per Share (EPS ₹) | 17.76 | 17.76 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 44 | 44 ▲ 0.0% |
| Share of Profit from Associates/JVs | -4 | -4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -22 | -22 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 3,014 | 3,014 ▲ 0.0% |
| Material Cost % of RevenueDerived | 20.00% | 20.00% |
| Employee Cost % of RevenueDerived | 12.68% | 12.68% |
| Other Cost % of RevenueDerived | 31.72% | 31.72% |
| Interest Coverage (x)Derived | 70.65x | 70.65x |
| Period | Mar 2018 | May 2018 | Mar 2019 | Jun 2019 | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,541 | 2,541 ▲ 0.0% | 2,693 ▲ 6.0% | 2,693 ▲ 0.0% | 2,655 ▼ 1.4% | 2,655 ▲ 0.0% | 2,881 ▲ 8.5% | 2,881 ▲ 0.0% | 3,192 ▲ 10.8% | 3,192 ▲ 0.0% | 3,406 ▲ 6.7% | 3,406 ▲ 0.0% | 3,578 ▲ 5.1% | 3,578 ▲ 0.0% | 3,809 ▲ 6.5% | 3,809 ▲ 0.0% | 3,780 ▼ 0.8% | 3,780 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 5.99% | — | -1.41% | -1.41% | 8.50% | — | 10.81% | 10.81% | 6.69% | 6.69% | 5.06% | 5.06% | 6.46% | 6.46% | -0.78% | -0.78% | |
| Other Income | 20 | 20 ▲ 0.0% | 37 ▲ 87.6% | 37 ▲ 0.0% | 57 ▲ 56.0% | 57 ▲ 0.0% | 70 ▲ 23.1% | 70 ▲ 0.0% | 95 ▲ 35.5% | 95 ▲ 0.0% | 69 ▼ 27.6% | 69 ▲ 0.0% | 47 ▼ 32.1% | 47 ▲ 0.0% | 68 ▲ 45.5% | 68 ▲ 0.0% | 85 ▲ 25.0% | 85 ▲ 0.0% | |
| Total Income | 2,560 | 2,560 ▲ 0.0% | 2,730 ▲ 6.6% | 2,730 ▲ 0.0% | 2,712 ▼ 0.6% | 2,712 ▲ 0.0% | 2,951 ▲ 8.8% | 2,951 ▲ 0.0% | 3,287 ▲ 11.4% | 3,287 ▲ 0.0% | 3,475 ▲ 5.7% | 3,475 ▲ 0.0% | 3,625 ▲ 4.3% | 3,625 ▲ 0.0% | 3,877 ▲ 7.0% | 3,877 ▲ 0.0% | 3,865 ▼ 0.3% | 3,865 ▲ 0.0% | |
820 | 820 ▲ 0.0% | 923 ▲ 12.5% | 923 ▲ 0.0% | 876 ▼ 5.1% | 876 ▲ 0.0% | 929 ▲ 6.1% | 929 ▲ 0.0% | 1,078 ▲ 16.0% | 1,078 ▲ 0.0% | 1,201 ▲ 11.5% | 1,201 ▲ 0.0% | 1,161 ▼ 3.4% | 1,161 ▲ 0.0% | 1,194 ▲ 2.9% | 1,194 ▲ 0.0% | 1,138 ▼ 4.7% | 1,138 ▲ 0.0% | ||
| Gross ProfitDerived | 1,721 | 1,721 ▲ 0.0% | 1,770 ▲ 2.9% | 1,770 ▲ 0.0% | 1,779 ▲ 0.5% | 1,779 ▲ 0.0% | 1,951 ▲ 9.7% | 1,951 ▲ 0.0% | 2,114 ▲ 8.3% | 2,114 ▲ 0.0% | 2,204 ▲ 4.3% | 2,204 ▲ 0.0% | 2,418 ▲ 9.7% | 2,418 ▲ 0.0% | 2,615 ▲ 8.2% | 2,615 ▲ 0.0% | 2,642 ▲ 1.0% | 2,642 ▲ 0.0% | |
| Gross Margin %Derived | 67.72% | 67.72% | 65.72% | 65.72% | 67.00% | 67.00% | 67.74% | 67.74% | 66.23% | 66.23% | 64.73% | 64.73% | 67.57% | 67.57% | 68.65% | 68.65% | 69.89% | 69.89% | |
1,001 | 1,001 ▲ 0.0% | 1,044 ▲ 4.3% | 1,044 ▲ 0.0% | 1,088 ▲ 4.2% | 1,088 ▲ 0.0% | 1,068 ▼ 1.8% | 1,068 ▲ 0.0% | 1,162 ▲ 8.8% | 1,162 ▲ 0.0% | 1,342 ▲ 15.5% | 1,342 ▲ 0.0% | 1,468 ▲ 9.4% | 1,468 ▲ 0.0% | 1,590 ▲ 8.3% | 1,590 ▲ 0.0% | 1,678 ▲ 5.5% | 1,678 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 719 | 719 ▲ 0.0% | 726 ▲ 0.8% | 726 ▲ 0.0% | 691 ▼ 4.8% | 691 ▲ 0.0% | 883 ▲ 27.9% | 883 ▲ 0.0% | 952 ▲ 7.9% | 952 ▲ 0.0% | 863 ▼ 9.4% | 863 ▲ 0.0% | 950 ▲ 10.1% | 950 ▲ 0.0% | 1,025 ▲ 8.0% | 1,025 ▲ 0.0% | 964 ▼ 6.0% | 964 ▲ 0.0% | |
| OPM %Derived | 28.32% | 28.32% | 26.94% | 26.94% | 26.01% | 26.01% | 30.66% | 30.66% | 29.84% | 29.84% | 25.33% | 25.33% | 26.54% | 26.54% | 26.91% | 26.91% | 25.50% | 25.50% | |
345 | 345 ▲ 0.0% | 337 ▼ 2.4% | 337 ▲ 0.0% | 347 ▲ 2.9% | 347 ▲ 0.0% | 380 ▲ 9.7% | 380 ▲ 0.0% | 320 ▼ 15.8% | 320 ▲ 0.0% | 255 ▼ 20.4% | 255 ▲ 0.0% | 190 ▼ 25.4% | 190 ▲ 0.0% | 188 ▼ 1.3% | 188 ▲ 0.0% | 178 ▼ 4.9% | 178 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 394 | 394 ▲ 0.0% | 406 ▲ 3.0% | 406 ▲ 0.0% | 380 ▼ 6.4% | 380 ▲ 0.0% | 573 ▲ 51.0% | 573 ▲ 0.0% | 688 ▲ 20.1% | 688 ▲ 0.0% | 677 ▼ 1.6% | 677 ▲ 0.0% | 795 ▲ 17.4% | 795 ▲ 0.0% | 906 ▲ 14.0% | 906 ▲ 0.0% | 850 ▼ 6.1% | 850 ▲ 0.0% | |
86 | 86 ▲ 0.0% | 101 ▲ 16.9% | 101 ▲ 0.0% | 71 ▼ 29.4% | 71 ▲ 0.0% | 114 ▲ 60.2% | 114 ▲ 0.0% | -149 ▼ 230.2% | -149 ▲ 0.0% | 42 ▲ 128.3% | 42 ▲ 0.0% | 67 ▲ 58.3% | 67 ▲ 0.0% | 91 ▲ 36.6% | 91 ▲ 0.0% | 71 ▼ 22.3% | 71 ▲ 0.0% | ||
| Effective Tax %Derived | 21.91% | 21.91% | 24.87% | 24.87% | 18.78% | 18.78% | 19.93% | 19.93% | -21.61% | -21.61% | 6.22% | 6.22% | 8.39% | 8.39% | 10.06% | 10.06% | 8.33% | 8.33% | |
| Total Profit for Period | 306 | 306 ▲ 0.0% | 303 ▼ 1.2% | 303 ▲ 0.0% | 302 ▼ 0.1% | 302 ▲ 0.0% | 455 ▲ 50.4% | 455 ▲ 0.0% | 837 ▲ 84.0% | 837 ▲ 0.0% | 627 ▼ 25.0% | 627 ▲ 0.0% | 724 ▲ 15.4% | 724 ▲ 0.0% | 803 ▲ 10.9% | 803 ▲ 0.0% | 775 ▼ 3.4% | 775 ▲ 0.0% | |
| Less: Non-controlling Interests | -1 | -1 ▲ 0.0% | -1 ▲ 16.7% | -1 ▲ 0.0% | -1 ▲ 12.9% | -1 ▲ 0.0% | 0 ▲ 101.6% | 0 ▲ 0.0% | -2 ▼ 23300.0% | -2 ▲ 0.0% | -12 ▼ 424.1% | -12 ▲ 0.0% | 1 ▲ 105.0% | 1 ▲ 0.0% | -4 ▼ 709.8% | -4 ▲ 0.0% | -0 ▲ 99.7% | -0 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 307 | 307 ▲ 0.0% | 303 ▼ 1.3% | 303 ▲ 0.0% | 303 ▼ 0.1% | 303 ▲ 0.0% | 455 ▲ 50.1% | 455 ▲ 0.0% | 839 ▲ 84.5% | 839 ▲ 0.0% | 640 ▼ 23.8% | 640 ▲ 0.0% | 724 ▲ 13.1% | 724 ▲ 0.0% | 806 ▲ 11.5% | 806 ▲ 0.0% | 775 ▼ 3.9% | 775 ▲ 0.0% | |
| Net Profit Margin %Derived | 12.09% | 12.09% | 11.26% | 11.26% | 11.41% | 11.41% | 15.79% | 15.79% | 26.28% | 26.28% | 18.78% | 18.78% | 20.22% | 20.22% | 21.17% | 21.17% | 20.51% | 20.51% | |
| PAT Growth YoY %Derived | — | — | -1.27% | — | -0.11% | -0.11% | 50.11% | — | 84.52% | 84.52% | -23.77% | -23.77% | 13.13% | 13.13% | 11.46% | 11.46% | -3.87% | -3.87% | |
| Earnings Per Share (EPS ₹) | 6.77 | 6.77 ▲ 0.0% | 6.68 ▼ 1.3% | 6.68 ▲ 0.0% | 6.67 ▼ 0.1% | 6.67 ▲ 0.0% | 10.23 ▲ 53.4% | 10.23 ▲ 0.0% | 19.02 ▲ 85.9% | 19.02 ▲ 0.0% | 14.50 ▼ 23.8% | 14.50 ▲ 0.0% | 16.58 ▲ 14.3% | 16.58 ▲ 0.0% | 18.48 ▲ 11.5% | 18.48 ▲ 0.0% | 17.76 ▼ 3.9% | 17.76 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 45 | 45 ▲ 0.0% | 45 ▲ 0.0% | 45 ▲ 0.0% | 45 ▲ 0.0% | 45 ▲ 0.0% | 44 ▼ 2.1% | 44 ▲ 0.0% | 44 ▼ 0.8% | 44 ▲ 0.0% | 44 ▲ 0.0% | 44 ▲ 0.0% | 44 ▼ 1.1% | 44 ▲ 0.0% | 44 ▲ 0.0% | 44 ▲ 0.0% | 44 ▲ 0.0% | 44 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -1 | -1 ▲ 0.0% | -2 ▼ 81.0% | -2 ▲ 0.0% | -6 ▼ 174.9% | -6 ▲ 0.0% | -4 ▲ 30.6% | -4 ▲ 0.0% | — ▲ 100.0% | — | -8 | -8 ▲ 0.0% | -4 ▲ 50.4% | -4 ▲ 0.0% | -12 ▼ 217.5% | -12 ▲ 0.0% | -4 ▲ 65.5% | -4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 94 | 94 ▲ 0.0% | -15 ▼ 116.1% | -15 ▲ 0.0% | -101 ▼ 568.4% | -101 ▲ 0.0% | 61 ▲ 160.7% | 61 ▲ 0.0% | 31 ▼ 50.1% | 31 ▲ 0.0% | -54 ▼ 277.6% | -54 ▲ 0.0% | -2 ▲ 97.2% | -2 ▲ 0.0% | -30 ▼ 1867.3% | -30 ▲ 0.0% | -22 ▲ 25.6% | -22 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 2,167 | 2,167 ▲ 0.0% | 2,324 ▲ 7.3% | 2,324 ▲ 0.0% | 2,332 ▲ 0.4% | 2,332 ▲ 0.0% | 2,378 ▲ 1.9% | 2,378 ▲ 0.0% | 2,599 ▲ 9.3% | 2,599 ▲ 0.0% | 2,798 ▲ 7.6% | 2,798 ▲ 0.0% | 2,830 ▲ 1.2% | 2,830 ▲ 0.0% | 2,972 ▲ 5.0% | 2,972 ▲ 0.0% | 3,014 ▲ 1.4% | 3,014 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 26.33% | 26.33% | 28.95% | 28.95% | 28.00% | 28.00% | 24.60% | 24.60% | 28.20% | 28.20% | 24.22% | 24.22% | 21.49% | 21.49% | 19.01% | 19.01% | 20.00% | 20.00% | |
| Employee Cost % of RevenueDerived | 10.02% | 10.02% | 10.39% | 10.39% | 11.28% | 11.28% | 10.73% | 10.73% | 9.96% | 9.96% | 10.80% | 10.80% | 11.06% | 11.06% | 11.74% | 11.74% | 12.68% | 12.68% | |
| Other Cost % of RevenueDerived | 29.38% | 29.38% | 28.40% | 28.40% | 29.71% | 29.71% | 26.35% | 26.35% | 26.44% | 26.44% | 28.59% | 28.59% | 29.97% | 29.97% | 30.00% | 30.00% | 31.72% | 31.72% | |
| Interest Coverage (x)Derived | 11.91x | 11.91x | 18.70x | 18.70x | 16.86x | 16.86x | 38.89x | 38.89x | 121.81x | 121.81x | 83.29x | 83.29x | 76.52x | 76.52x | 90.67x | 90.67x | 70.65x | 70.65x |
EMAMI segment analysis : revenue and profit mix.
Disclosed business segments at EMAMI with their share of revenue and profit, switchable between consolidated and standalone reporting.
EMAMI discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for EMAMI.
Our AI distills the core fundamental drivers supporting EMAMI, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
EMAMI's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROE 26.53% and ROCE 26.21% substantially exceed peer averages; superior capital efficiency demonstrated.
Operating margin 20.80% reflects strong pricing power and consistent cost discipline across cycles.
Minimal debt-to-equity ratio 0.0004x provides fortress balance sheet and maximum strategic flexibility.
Promoter holding stable at 54.47% ensures long-term brand stewardship and management alignment.
Operating cash flow ₹794 Cr underpins dividend sustainability and organic growth capacity reliably.
Key Risks.
Latest quarterly EPS declined 11.7% YoY despite operational scale, signaling earnings pressure.
Revenue declined 3.9% YoY (TTM), indicating potential demand softness in core personal care markets.
FII holdings eased from 14.38% to 10.93%, reflecting reduced foreign investor confidence materially.
Dividend payout ratio 67.64% limits reinvestment capacity for organic growth and innovation initiatives.
52-week price range ₹618.00 to ₹361.15 indicates elevated volatility and investor uncertainty.
Flip Conditions.
Valuation risk. a P/E above 28 (~0.9× the sector multiple of 29.8) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 22% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 1.36%.
EMAMI peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — EMAMI is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
EMAMI chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for EMAMI — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
EMAMI delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for EMAMI over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in EMAMI stood at 45.1% of traded volume, against a 20-day average of 55.0%.
EMAMI announcements: results, concalls, ratings, M&A.
Filings EMAMI sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
EMAMI files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 165 documents below.
Updates
Emami Limited has informed the Exchange regarding 'Consideration of Interim Dividend for FY 2026-27'.
Post Buyback Public Announcement
Emami Limited has informed the Exchange about post Buyback Public Announcement
Closure of Buy Back
Emami Limited has informed the Exchange regarding Closure of Buy Back with effect from October 09, 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Emami Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
Emami Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Investor decks & rating reports.
EMAMI dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue EMAMI has declared, sequenced by announce and record date.
EMAMI corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About EMAMI: business, sector, key facts.
What EMAMI does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
EMAMI operates in the Personal Care industry under the Fast Moving Consumer Goods sector, listed as NSE: EMAMILTD, BSE: 531162.
Emami Limited is a prominent Indian fast-moving consumer goods (FMCG) company specializing in the manufacture and marketing of personal care and healthcare products. Established in 1974 and headquartered in Kolkata, the company boasts a diverse portfolio of brands catering to a wide range of consumer needs.
A significant portion of Emami's business revolves around its flagship brands, each with a distinct product line. The Boroplus brand offers a comprehensive selection of ayurvedic products, including antiseptic cream, prickly heat powder, and various lotions and gels. Navratna, another key brand, focuses on cooling and ayurvedic oils, talcs, and other products for relief and skincare. Zandu contributes healthcare products ranging from balms and ointments to ayurvedic remedies. These three brands alone represent a considerable portion of Emami's market share and revenue.
Beyond these core brands, Emami's portfolio showcases a strong commitment to diverse product categories. This includes Fair and Handsome men's skincare, Kesh King haircare, Mentho Plus balms, Dermicool prickly heat powder, Emami 7 Oils in One hair products, HE deodorants, and various other brands catering to specific needs like hair color (Emami Diamond Shine and Emami Gold), fairness creams (Emami Naturally Fair), and oral care (Ayucare). The Cream21 brand offers a broad selection of moisturizers, lotions, and other skin products, aiming to cover a wide spectrum of skin types and ages.
The company's success stems from its strategic focus on leveraging the popularity of Ayurvedic ingredients and traditional remedies in India, incorporating them into their product formulations. Emami's extensive distribution network and consistent marketing efforts have helped establish its brands as household names, securing strong market positions within India's vast consumer goods sector. While primarily focused on the domestic Indian market, Emami also exports its products internationally, demonstrating a growing global presence.
In essence, Emami Limited's business model hinges on a diversified portfolio of strong brands, a keen understanding of consumer preferences within the Indian market, and a strategic blend of traditional and modern product formulations. This successful strategy, combined with effective distribution and marketing, allows Emami to maintain a significant presence within the highly competitive FMCG landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- BAJAJ CONSUMER CARE (BAJAJCON) Share PricePeer
- COLGATE PALMOLIVE (COLPAL) Share PricePeer
- CUPID (CUPID) Share PricePeer
- DABUR INDIA (DABUR) Share PricePeer
- GILLETTE INDIA (GILLETTE) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about EMAMI (EMAMILTD).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of EMAMI (EMAMILTD)?
The current share price of EMAMI (EMAMILTD) is ₹370.90. Today, the stock has declined by ₹1.90 (0.51%), trading in a range of ₹368.35 to ₹374.00. The stock opened at ₹372.80 with a trading volume of 2,11,179 shares.
02Is EMAMI stock a good investment for long-term?
EMAMI can be considered for long-term investment based on several factors. The company has a market capitalization of ₹16,163.59 Cr., P/E ratio of 21.6, ROE of 26.67%, and ROCE of 26.27%. The dividend yield stands at 2.73%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of EMAMI stock?
The 52-week high price of EMAMI (EMAMILTD) is ₹553.30, while the 52-week low is ₹361.15. Currently trading at ₹370.90, the stock is 2.7% above its 52-week low and 32.97% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy EMAMI stock at the current price?
Whether to buy EMAMI stock at ₹370.90 depends on multiple factors. The stock is currently trading with a P/E ratio of 21.6 and P/B ratio of 5.53. Today's performance shows a loss of 0.51%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of EMAMI and when is the next dividend?
EMAMI offers a dividend yield of 2.73%, which means for every ₹100 invested at the current price of ₹370.90, you can expect to receive approximately ₹2.73 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of EMAMI?
EMAMI's key financial metrics include: P/E Ratio: 21.6, P/B Ratio: 5.53, ROE: 26.67%, ROCE: 26.27%, Dividend Yield: 2.73%, EPS: ₹17.27, Book Value: ₹66.99, and Debt-to-Equity: 0.02. The company's market cap stands at ₹16,163.59 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is EMAMI stock performing today in the market?
EMAMI stock opened at ₹372.80 and is currently trading at ₹370.90, showing a decline of ₹1.90 (0.51%). The intraday high is ₹374.00 and low is ₹368.35. The trading volume stands at 2,11,179 shares, indicating moderate market participation today.
08What is the P/E ratio of EMAMI and what does it indicate?
EMAMI has a Price-to-Earnings (P/E) ratio of 21.6, which means investors are willing to pay 21.60 for every ₹1 of earnings. With an EPS of ₹17.27, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about EMAMI (EMAMILTD) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.